Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of mRNA Vaccines and mRNA Drugs
1.2 Key Market Segments
1.2.1 mRNA Vaccines and mRNA Drugs Segment by Type
1.2.2 mRNA Vaccines and mRNA Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 mRNA Vaccines and mRNA Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global mRNA Vaccines and mRNA Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global mRNA Vaccines and mRNA Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 mRNA Vaccines and mRNA Drugs Market Competitive Landscape
3.1 Global mRNA Vaccines and mRNA Drugs Sales by Manufacturers (2019-2024)
3.2 Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA Vaccines and mRNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA Vaccines and mRNA Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA Vaccines and mRNA Drugs Sales Sites, Area Served, Product Type
3.6 mRNA Vaccines and mRNA Drugs Market Competitive Situation and Trends
3.6.1 mRNA Vaccines and mRNA Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA Vaccines and mRNA Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 mRNA Vaccines and mRNA Drugs Industry Chain Analysis
4.1 mRNA Vaccines and mRNA Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of mRNA Vaccines and mRNA Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 mRNA Vaccines and mRNA Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2019-2024)
6.3 Global mRNA Vaccines and mRNA Drugs Market Size Market Share by Type (2019-2024)
6.4 Global mRNA Vaccines and mRNA Drugs Price by Type (2019-2024)
7 mRNA Vaccines and mRNA Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccines and mRNA Drugs Market Sales by Application (2019-2024)
7.3 Global mRNA Vaccines and mRNA Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA Vaccines and mRNA Drugs Sales Growth Rate by Application (2019-2024)
8 mRNA Vaccines and mRNA Drugs Market Segmentation by Region
8.1 Global mRNA Vaccines and mRNA Drugs Sales by Region
8.1.1 Global mRNA Vaccines and mRNA Drugs Sales by Region
8.1.2 Global mRNA Vaccines and mRNA Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA Vaccines and mRNA Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA Vaccines and mRNA Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA Vaccines and mRNA Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA Vaccines and mRNA Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA Vaccines and mRNA Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Thermo Fisher
9.1.1 Thermo Fisher mRNA Vaccines and mRNA Drugs Basic Information
9.1.2 Thermo Fisher mRNA Vaccines and mRNA Drugs Product Overview
9.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Product Market Performance
9.1.4 Thermo Fisher Business Overview
9.1.5 Thermo Fisher mRNA Vaccines and mRNA Drugs SWOT Analysis
9.1.6 Thermo Fisher Recent Developments
9.2 Merck
9.2.1 Merck mRNA Vaccines and mRNA Drugs Basic Information
9.2.2 Merck mRNA Vaccines and mRNA Drugs Product Overview
9.2.3 Merck mRNA Vaccines and mRNA Drugs Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck mRNA Vaccines and mRNA Drugs SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Qiagen N.V.
9.3.1 Qiagen N.V. mRNA Vaccines and mRNA Drugs Basic Information
9.3.2 Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Overview
9.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Market Performance
9.3.4 Qiagen N.V. mRNA Vaccines and mRNA Drugs SWOT Analysis
9.3.5 Qiagen N.V. Business Overview
9.3.6 Qiagen N.V. Recent Developments
9.4 CureVac
9.4.1 CureVac mRNA Vaccines and mRNA Drugs Basic Information
9.4.2 CureVac mRNA Vaccines and mRNA Drugs Product Overview
9.4.3 CureVac mRNA Vaccines and mRNA Drugs Product Market Performance
9.4.4 CureVac Business Overview
9.4.5 CureVac Recent Developments
9.5 In-Cell-Art
9.5.1 In-Cell-Art mRNA Vaccines and mRNA Drugs Basic Information
9.5.2 In-Cell-Art mRNA Vaccines and mRNA Drugs Product Overview
9.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Product Market Performance
9.5.4 In-Cell-Art Business Overview
9.5.5 In-Cell-Art Recent Developments
9.6 eTheRNA
9.6.1 eTheRNA mRNA Vaccines and mRNA Drugs Basic Information
9.6.2 eTheRNA mRNA Vaccines and mRNA Drugs Product Overview
9.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Product Market Performance
9.6.4 eTheRNA Business Overview
9.6.5 eTheRNA Recent Developments
9.7 Takara Bio Inc.
9.7.1 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Basic Information
9.7.2 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Overview
9.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Market Performance
9.7.4 Takara Bio Inc. Business Overview
9.7.5 Takara Bio Inc. Recent Developments
9.8 Sangamo Therapeutics
9.8.1 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Basic Information
9.8.2 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Overview
9.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Market Performance
9.8.4 Sangamo Therapeutics Business Overview
9.8.5 Sangamo Therapeutics Recent Developments
9.9 Roche CustomBiotech
9.9.1 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Basic Information
9.9.2 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Overview
9.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Market Performance
9.9.4 Roche CustomBiotech Business Overview
9.9.5 Roche CustomBiotech Recent Developments
9.10 BioNTech
9.10.1 BioNTech mRNA Vaccines and mRNA Drugs Basic Information
9.10.2 BioNTech mRNA Vaccines and mRNA Drugs Product Overview
9.10.3 BioNTech mRNA Vaccines and mRNA Drugs Product Market Performance
9.10.4 BioNTech Business Overview
9.10.5 BioNTech Recent Developments
9.11 Tiba Biotechnology
9.11.1 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Basic Information
9.11.2 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Overview
9.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Market Performance
9.11.4 Tiba Biotechnology Business Overview
9.11.5 Tiba Biotechnology Recent Developments
9.12 TriLink Bio Technologies
9.12.1 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Basic Information
9.12.2 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Overview
9.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Market Performance
9.12.4 TriLink Bio Technologies Business Overview
9.12.5 TriLink Bio Technologies Recent Developments
9.13 Argos Therapeutics
9.13.1 Argos Therapeutics mRNA Vaccines and mRNA Drugs Basic Information
9.13.2 Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Overview
9.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Market Performance
9.13.4 Argos Therapeutics Business Overview
9.13.5 Argos Therapeutics Recent Developments
9.14 Moderna Therapeutics
9.14.1 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Basic Information
9.14.2 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Overview
9.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Market Performance
9.14.4 Moderna Therapeutics Business Overview
9.14.5 Moderna Therapeutics Recent Developments
9.15 NEB
9.15.1 NEB mRNA Vaccines and mRNA Drugs Basic Information
9.15.2 NEB mRNA Vaccines and mRNA Drugs Product Overview
9.15.3 NEB mRNA Vaccines and mRNA Drugs Product Market Performance
9.15.4 NEB Business Overview
9.15.5 NEB Recent Developments
9.16 Ethris
9.16.1 Ethris mRNA Vaccines and mRNA Drugs Basic Information
9.16.2 Ethris mRNA Vaccines and mRNA Drugs Product Overview
9.16.3 Ethris mRNA Vaccines and mRNA Drugs Product Market Performance
9.16.4 Ethris Business Overview
9.16.5 Ethris Recent Developments
9.17 Aldevron
9.17.1 Aldevron mRNA Vaccines and mRNA Drugs Basic Information
9.17.2 Aldevron mRNA Vaccines and mRNA Drugs Product Overview
9.17.3 Aldevron mRNA Vaccines and mRNA Drugs Product Market Performance
9.17.4 Aldevron Business Overview
9.17.5 Aldevron Recent Developments
9.18 Promega
9.18.1 Promega mRNA Vaccines and mRNA Drugs Basic Information
9.18.2 Promega mRNA Vaccines and mRNA Drugs Product Overview
9.18.3 Promega mRNA Vaccines and mRNA Drugs Product Market Performance
9.18.4 Promega Business Overview
9.18.5 Promega Recent Developments
9.19 Translate Bio
9.19.1 Translate Bio mRNA Vaccines and mRNA Drugs Basic Information
9.19.2 Translate Bio mRNA Vaccines and mRNA Drugs Product Overview
9.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Product Market Performance
9.19.4 Translate Bio Business Overview
9.19.5 Translate Bio Recent Developments
10 mRNA Vaccines and mRNA Drugs Market Forecast by Region
10.1 Global mRNA Vaccines and mRNA Drugs Market Size Forecast
10.2 Global mRNA Vaccines and mRNA Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe mRNA Vaccines and mRNA Drugs Market Size Forecast by Country
10.2.3 Asia Pacific mRNA Vaccines and mRNA Drugs Market Size Forecast by Region
10.2.4 South America mRNA Vaccines and mRNA Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of mRNA Vaccines and mRNA Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global mRNA Vaccines and mRNA Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of mRNA Vaccines and mRNA Drugs by Type (2025-2030)
11.1.2 Global mRNA Vaccines and mRNA Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of mRNA Vaccines and mRNA Drugs by Type (2025-2030)
11.2 Global mRNA Vaccines and mRNA Drugs Market Forecast by Application (2025-2030)
11.2.1 Global mRNA Vaccines and mRNA Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global mRNA Vaccines and mRNA Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
